Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Knowing when to increase your retirement contributions can significantly boost your savings. Explore strategies to enhance your financial future.
10,086 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Ready to get top dollar for your car without the stress? These six practical steps walk you through prep, pricing, li...
Investors increasingly focus on how broadstone lease (bnl) earnings translate into cash flow and dividends. This guid...
Dive into how to read myriad genetics (mygn) 2025 earnings transcripts, spot growth drivers, assess risk, and build a...
Bitcoin struggled to push past the $67K mark as Ethereum sales by Vitalik Buterin weigh on sentiment, while XRP spot ...
Circle announced a 77% year-over-year surge in Q4 2025 revenue and a USDC supply topping $75 billion, underscoring ac...
A regional energy shock is unfolding as the Strait of Hormuz stays shut and exporters curtail shipments. The disrupti...
loandepot reports $108m loss for 2025, reflecting a tougher fourth quarter even as annual revenue and pull-through ma...
AI is reshaping hiring in three AI-driven domains, even as revenue growth decouples from headcount. The shift signals...
Netflix has transformed how we watch TV, but investors are asking if the stock can reach $200. This article breaks do...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...
Oklo is building small modular reactors with a bold future. But should oklo stock while it trades under $55 be part o...